LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Did Exiting Medicare’s Bundled Program Cost Rothman?
Large Joints and Extremities

Did Exiting Medicare’s Bundled Program Cost Rothman?

June 20, 2022 2 min read Premium comments

Advertisement

Secondary#rothmanorthopaedicinstitute#reimbursement

When Medicare moved the reimbursement goalposts for total hip (THA) and knee arthroplasty (TKA), the Rothman Orthopaedic Institute withdrew from the Bundled Payments for Care Improvement – Advanced. A team of the facility’s researchers set out to determine if this meant a drop in the quality of their service.

Their work, “Life After BPCI: High Quality Total Knee and Hip Arthroplasty Care Can Still Exist Outside of a Bundled Payment Program,” appears in the July 2022 edition of The Journal of Arthroplasty.

Co-author P. Maxwell Courtney, M.D. associate professor of orthopedic surgery at the Rothman Orthopaedic Institute at Thomas Jefferson University in Philadelphia, explained the study to OTW: “We at Rothman have been innovators in value-based care, participating in bundled payment models with Medicare since 2015.”

“In a typical, fee-for-service model for total hip and knee replacements, each provider bills the insurance company for their services, from the surgeon, the hospital, the physical therapist, and the rehabilitation facility, with minimal coordination of care. In order to cut costs, Medicare developed bundled payment programs to provide for one payment for all of the care of the patient over a 90-day period.”

“Early on in our experience, bundled payments for THA and TKA were widely successful, helped reduce our readmission rate, sent a large majority of our patients home—and not to a rehabilitation facility—and allowed us to perform many procedures at low-cost, outpatient centers.”

But then Medicare changed the rules.

“When Medicare developed a new program in 2020 (Bundled Payments for Care Improvement – Advanced), they changed the methodology for how they calculated their reimbursement price,” added Dr. Courtney. “Despite being in the top 10% of the country in all of our outcome metrics, our practice lost millions of dollars and had to withdraw from the bundled payment program with Medicare.”

The team decided to consider surgeries from January 1, 2020, to March 30, 2021 (after the withdrawal from the Medicare program). The researchers looked at 2,737 primary TKA and 2,009 primary THA patients, comparing them to 1,203 TKA and 1,088 THA patients whose procedures were done while the facility was still part of the Medicare bundled payment plan.

Advertisement

Patients who underwent TKA after the bundle departure had a shorter length of stay (1.4 vs 1.8 days). TKA and THA patients were significantly less likely to be discharged to a rehabilitation facility (5.6% vs 19.2% and 6.0% vs 10.0%, respectively). After controlling for confounding variables, the team found that those undergoing post-bundle TKAs had lower complications but experienced no difference in 90-day readmission.

“We wanted to report our data in the year following our exit from the Bundled Payments for Care Improvement – Advanced and found that we are still providing quality hip and knee care, despite no longer participating in the Medicare bundle,” stated Dr. Courtney to OTW. We hope that policy makers can look at our experience and appropriately incentivize practices to enroll in value-based care models and not penalize surgeons for providing quality care.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy